BARCELONA - Sales forecasts for Novartis's new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease.
BARCELONA - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.
STOCKHOLM - A hospital in the Swedish capital is investigating a possible case of Ebola, Swedish media reported on Sunday.
MONROVIA/CONAKRY - Crowds sang and danced in the streets of a seaside neighborhood in Liberia on Saturday as the government lifted quarantine measures designed to contain the spread of the deadly Ebola virus.
BARCELONA - A major clinical study has raised concerns about a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. group Amgen last year.
BARCELONA - Swiss engineers, famous for making the world's finest watches, are turning their hands to cardiology with a prototype battery-less pacemaker based on a self-winding wristwatch.
BARCELONA - An experimental cholesterol-lowering drug from Sanofi and Regeneron Pharmaceuticals roughly halved the number of heart attacks and strokes in a clinical trial, researchers reported on Sunday.
DAKAR - The World Food Programme needs to raise $70 million to feed 1.3 million people at risk from shortages in Ebola-quarantined areas in West Africa, with the agency's resources already stretched by several major humanitarian crises, its regional director said.
DAKAR (Thomson Reuters Foundation) - Liberia is building five new Ebola treatment centers each with capacity for 100 beds as it struggles to contain the spread of world’s biggest outbreak of the deadly disease, government and health officials said on Saturday.
Video: Health Reform Watch
A series that looks at all facets of cancer, written by Debra Sherman, a lung cancer patient who succumbed to the disease on April 22, 2014. Debra covered the health beat for Reuters for more than a decade and drew on her knowledge about health, her contacts in the industry and her personal experiences to report this series. Full Article